CalciMedica is trading at $1.25, up 8.70% versus the previous close; available reporting has not established a direct cause for the move.
- No new CalciMedica announcement explaining the October 22 move was identified; its investor-relations press-release page lists 2026 releases only through September 8.
- Biotech ETF XBI was up 3.64% pre-market, a possible sector backdrop, while broader market indicators were down.